Comparison of selected endocrine parameters during luteal phase and pregnancy in German Shepherd dogs and Beagles.
Concentrations of progesterone, prolactin and relaxin in serum at predetermined intervals after ovulation (day 0) in non-pregnant and pregnant normocyclic Beagles were assayed and results compared with those observed in German Shepherd dogs (GSD) in a previous study. The goal was to determine possible reproductive hormone specificities related to the GSD breed. Furthermore, the effects of medroxyprogesterone acetate (MPA)-treatment in non-pregnant Beagles and of progesterone supplementation in pregnant Beagles on the hormone concentrations were examined. Mean concentrations of progesterone and prolactin were not different in the non-pregnant Beagles compared with those seen in non-pregnant GSD, except at days 50-60, when progesterone concentrations were found to be higher in Beagles (p < 0.05). Mean progesterone concentrations in pregnant Beagles at days 50-60 after ovulation (day 0) were higher (p < 0.05) than in GSD at that time, but not at earlier time periods. Prolactin concentrations were higher (p < 0.05) in Beagles throughout pregnancy compared with those in the GSD. Mean relaxin concentrations were numerically but not significantly lower in GSD than in Beagles throughout pregnancy. A 10-day oral MPA treatment did not affect progesterone or prolactin secretion in normocyclic non-pregnant Beagles. Medroxyprogesterone acetate serum concentrations were approximately 3.9 ng/ml during treatment and decreased to 0.42 and 0.021 ng/ml within 5 and 15 days after end of treatment, respectively. Intramuscular progesterone supplementation from days 30 to 40 in pregnant Beagles resulted in higher concentrations of progesterone in the 36- to 45-day time periods; prolactin and relaxin concentrations were not significantly affected during or after treatment compared with administration of placebo. The results suggest a tendency towards deficient luteal function in the short-cycle GSD bitches previously studied, which in pregnancy may reflect the observed decreased prolactin concentrations; the possibility that GSD relaxin secretion is deficiency required needs further study. As oral treatment with MPA did not affect progesterone and prolactin release, it may be useful for studying luteal function in pregnant bitches with suspected hypoluteoidism.
Günzel-Apel
A R
AR
Small Animal Clinic, University of Veterinary Medicine, Hannover, Germany. Rose.Guenzel-Apel@tiho-hannover.de
Beste
N
N
Nottorf
S
S
Eschricht
F
F
Hoppen
H O
HO
Dieleman
S
S
Einspanier
A
A
D000818:Animals; D003271:Contraceptive Agents, Female / Q000494:pharmacology; D004285:Dogs / Q000235:genetics* / Q000502:physiology; D005260:Female; D008183:Luteal Phase / Q000097:blood / Q000235:genetics / Q000502:physiology*; D017258:Medroxyprogesterone Acetate / Q000494:pharmacology; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000235:genetics; D011374:Progesterone / Q000097:blood*; D011388:Prolactin / Q000097:blood*; D012065:Relaxin / Q000097:blood*; D013997:Time Factors
D003271:Contraceptive Agents, Female; D011374:Progesterone; D011388:Prolactin; D012065:Relaxin; D017258:Medroxyprogesterone Acetate